BIOREM Inc.
BRM.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.77% | -92.41% | 552.80% | -3.53% | -85.08% |
| Total Depreciation and Amortization | -6.30% | -26.14% | 147.53% | 0.18% | -62.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.04% | -167.92% | 370.17% | 1.39% | -71.06% |
| Change in Net Operating Assets | 407.22% | -1,003.28% | 94.97% | -168.40% | 216.93% |
| Cash from Operations | 370.99% | -153.21% | 263.61% | -144.75% | 10,889.01% |
| Capital Expenditure | -1,610.81% | -- | 100.00% | 99.00% | -403.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,610.81% | -- | 100.00% | 99.00% | -403.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -59.03% | 35.75% | -18.65% | 25.34% | -133.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -836.41% | 113.18% | -18.99% | 26.41% | -135.56% |
| Foreign Exchange rate Adjustments | 97.34% | -180.43% | 553.17% | 211.63% | 115.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 307.55% | -159.61% | 269.24% | -154.52% | 4,090.91% |